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Homeostasis in the bone tissue primarily depends on the balance of the ac-
tivities of osteoclasts and osteoblasts, primarily involved in bone formation 
and turnover (Zaidi 2007; Khosla et al 2005). Osteoblasts maintain the bone 
mass, and intervene in bone injuries repair. The limited number of therapeu-
tic agents able to promote osteogenesis ingenerated great interest addressed 
to manipulate the activity of osteoblasts. Insights in the events leading to the 
differentiation and proliferation of osteoblasts might allow uncover potential 
molecular therapy targets to control the complex mechanisms underlying the 
skeletal remodeling (Marie 2015; Kawai et al 2011). Oscillations of calcium 
act crucially during the remodeling of bone, affecting both the differentiation 
and proliferation of osteoblasts. Signal transduction pathways contribute to 
the differentiation and metabolic activities of osteoblasts, with special regard 
to calcium-related signaling (Kimple et al 2011, Keinan et al 2014), including 
the Phosphoinositide (PI) pathway and related Phospholipases C (PLCs). 
In order to evaluate the role of PLC enzymes’ family in human osteoblasts 
(HOBs), we analyzed the expression of PLC genes and the localization of 
PLC enzymes both in cultured HOBs and in in vitro differentiating HOBs 
after 3, 10, 17 and 23 days. Our results confirm the transcription of most PLC 
genes and the presence of a number of PLC enzymes in HOBs, differently 
localized in the nucleus, in the cytoplasm or both, as well as in cell protru-
sions. The presence of PLC enzymes within the HOBs suggests the activation 
of the PI nuclear cycle in HOBs. Along both the culture and differentiation 
culture periods, transcripts of splicing variants of selected PLC genes were 
detected and the localization of most PLC enzymes varied, with special re-
gard to enzymes belonging to the PLC ,  and  sub-families. The behavior 
of selected PLC enzymes will be discussed more in detail. The presented 
results overall suggest that PLC signaling might provide further insights into 
the complex signal transduction network in bone remodeling, also represent-
ing promising molecular targets. 
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